CMS National Provider Directory Launches March 2026 Without Public Pricing

The Development

CMS launched its National Provider Directory in March 2026, according to disclosures at the American Society for Testing and Policy annual meeting. The agency released no pricing structure, adoption targets, or technical specifications alongside the launch. For healthcare enterprises evaluating provider data infrastructure, this creates a planning problem: the federal government now operates a directory service with unknown cost implications and unclear integration requirements.

The timing matters because USCDI Version 3 became mandatory January 1, 2026, forcing health systems to upgrade data exchange capabilities regardless of vendor readiness. Adding a new federal directory without published interoperability standards compounds integration workload at the worst possible time.

What Changed for Buyers

Provider directories are expensive infrastructure. Most health systems pay between $200,000 and $800,000 annually for commercial solutions that maintain physician credentialing data, location information, and referral networks. The CMS directory enters a market where Epic, Availity, and Symphony already compete. Without disclosed pricing, buyers cannot model whether the federal option represents a cost reduction or an additional layer.

The lack of technical documentation creates three immediate risks. First, integration teams cannot estimate implementation hours without API specifications or data schema details. Second, compliance officers cannot assess whether using the CMS directory satisfies information blocking regulations under the 21st Century Cures Act. Third, procurement teams cannot compare the federal offering against commercial alternatives on total cost of ownership.

The TEFCA framework — the federal interoperability network that exchanged 500 million health records as of late 2025 — does not yet specify how the CMS directory connects to existing qualified health information networks. That means even organizations already invested in TEFCA infrastructure face unknown integration costs.

The Missing Data Points

CMS provided no pilot participants, no performance benchmarks, and no adoption timeline. Commercial directory vendors typically publish customer counts and match rate accuracy (the percentage of provider records correctly linked across systems). The absence of these metrics means buyers cannot evaluate directory quality against incumbent solutions.

For multi-state health systems, accuracy matters more than coverage. A directory with 95% of U.S. providers but 75% match accuracy creates more operational cost than a smaller directory with 98% accuracy. Without published benchmarks, procurement teams cannot perform this comparison.

The pricing gap is equally significant. Some health information exchanges charge per-query fees; others use flat annual licensing. The CMS model remains undisclosed. For a 400-bed hospital system processing 50,000 provider lookups monthly, the difference between these pricing structures amounts to six-figure annual variance.

What the Regulatory Timeline Shows

The HTI-5 proposed rule closed its comment period February 27, 2026, one week before the directory launch. That rule addressed information blocking exceptions and prior authorization requirements but did not mandate use of the CMS directory. This suggests the directory functions as an optional resource rather than a compliance requirement, but CMS has not confirmed that interpretation.

The HTI-6 rule, expected summer 2026, may clarify directory use requirements. Buyers waiting for that guidance risk being late to integration if the final rule imposes retroactive compliance dates. Buyers moving forward risk implementing against specifications that change.

What to Watch

Three vendor responses will signal market impact. First, whether Epic and Oracle Health Systems publish integration guides for the CMS directory within 60 days. Their absence would indicate technical barriers or competitive resistance. Second, whether any large health system announces CMS directory adoption as a replacement for commercial services. That would establish pricing viability. Third, whether the Office of the National Coordinator publishes USCDI mapping specifications for the directory. Without that, the directory exists outside the mandatory interoperability framework.

For procurement teams, the practical move is requesting commercial vendors price both standalone directory services and integration with the eventual CMS offering. That creates optionality without locking in either path. For compliance teams, the move is documenting that CMS provided insufficient specifications to enable adoption, creating an information blocking safe harbor if the HTI-6 rule later imposes requirements.

The gap between launch announcement and operational detail matters because it extends planning cycles. A directory without pricing, without technical specs, and without adoption proof cannot inform a budget or a contract negotiation. Until CMS publishes those details, the National Provider Directory remains a placeholder — announced but not actionable.